Assessment of disease activity in Graves' orbitopathy. [PDF]
Potvin ARGG +5 more
europepmc +1 more source
Selenium Supplementation in Graves' Orbitopathy: Effects on Blood Concentrations and Clinical Outcomes. [PDF]
Lumyongsatien M +5 more
europepmc +1 more source
Unravelling the pathogenic mechanisms in Graves' orbitopathy. [PDF]
Lee ACH, Kahaly GJ.
europepmc +1 more source
Sarilumab in the management of Graves orbitopathy with low clinical activity scores. [PDF]
Pérez-Moreiras J +3 more
europepmc +1 more source
Correction: Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy. [PDF]
Kim W +7 more
europepmc +1 more source
Extracellular vesicles in Graves' disease and Graves' orbitopathy: immunoregulatory mechanisms, biomarkers, and therapeutic potentials. [PDF]
Chen Y +5 more
europepmc +1 more source
Modulation of gut microbiota in Graves' orbitopathy: Prevotella dominance and atorvastatin's impact. [PDF]
Wang D +12 more
europepmc +1 more source
The impact of graves' orbitopathy on anterior segment structures and choroidal parameters. [PDF]
Sevimli N +3 more
europepmc +1 more source
Pediatric Graves' orbitopathy: TRAb and FT-3 are also prognostic factors in children-A tertiary center study. [PDF]
Al-Ghazzawi K +7 more
europepmc +1 more source
Higher serum IgG4 levels correlate with better quality of life in mild Graves' orbitopathy: a preliminary report. [PDF]
Lin CH +11 more
europepmc +1 more source

